Growth hormone-activated STAT5 may indirectly stimulate IGF-I gene transcription through HNF-3γ

Molecular Endocrinology

Volumn 23, Issue 12, 2009, Pages 2026-2037

  Eleswarapu, Satyanarayana ^a,b   Ge, Xiaomei ^a   Wang, Ying ^a,c   Yu, Jie ^a,d   Jiang, Honglin ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c Eton Bioscience Inc   (United States)

^d SICHUAN AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; SOMATOMEDIN C; STAT5 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHO CELL; CONTROLLED STUDY; COW; FEMALE; GENE EXPRESSION REGULATION; HORMONAL REGULATION; LIVER; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; BINDING SITES; CATTLE; CELLS, CULTURED; CHO CELLS; CHROMATIN IMMUNOPRECIPITATION; CRICETINAE; CRICETULUS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENE EXPRESSION REGULATION; GROWTH HORMONE; HEPATOCYTE NUCLEAR FACTOR 3-GAMMA; INSULIN-LIKE GROWTH FACTOR I; MICE; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; STAT5 TRANSCRIPTION FACTOR;

BOVINAE; MAMMALIA;

EID: 73249130441     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2009-0178     Document Type: Article

References (56)

1. Stewart CE, Rotwein P 1996 Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 76:1005-1026
2. LeRoith D 2008 Clinical relevance of systemic and local IGF-I: lessons from animal models. Pediatr Endocrinol Rev 5(Suppl 2): 739-743
3. Pollak M 2008 Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8:915-928
4. Samani AA, Yakar S, LeRoith D, Brodt P 2007 The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28:20-47
5. Meyer-Schwickerath R, Pfeiffer A, Blum WF, Freyberger H, Klein M, Lösche C, Röllmann R, Schatz H 1993 Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. J Clin Invest 92:2620-2625
6. Wilkinson-Berka JL, Wraight C, Werther G 2006 The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy. Curr Med Chem 13:3307-3317
7. Clemmons DR 2007 Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer. Nat Rev Drug Discov 6:821-833
8. Bartke A 2005 Role of the growth hormone/insulin-like growth factor system in mammalian aging. Endocrinology 146:3718-3723
9. D'Ercole AJ, Stiles AD, Underwood LE 1984 Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci USA 81:935-939
10. Daughaday WH, Rotwein P 1989 Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 10:68-91
11. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, LeRoith D 1999 Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 96:7324-7329
12. Sjögren K, Liu JL, Blad K, Skrtic S, Vidal O, Wallenius V, LeRoith D, Törnell J, Isaksson OG, Jansson JO, Ohlsson C 1999 Liverderived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci USA 96:7088-7092
13. Bichell DP, Kikuchi K, Rotwein P 1992 Growth hormone rapidly activates insulin-like growth factor I gene transcription in vivo. Mol Endocrinol 6:1899-1908
14. Woelfle J, Billiard J, Rotwein P 2003 Acute control of insulin-like growth factor-I gene transcription by growth hormone through Stat5b. J Biol Chem 278:22696-22702
15. Davey HW, Xie T, McLachlan MJ, Wilkins RJ, Waxman DJ, Grattan DR 2001 STAT5b is required for GH-induced liver IGF-I gene expression. Endocrinology 142:3836-3841
16. Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ, Davey HW 1997 Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA 94:7239-7244
17. Chia DJ, Ono M, Woelfle J, Schlesinger-Massart M, Jiang H, Rotwein P 2006 Characterization of distinct Stat5b binding sites that mediate growth hormone-stimulated IGF-I gene transcription. J Biol Chem 281:3190-3197
18. Eleswarapu S, Gu Z, Jiang H 2008 Growth hormone regulation of insulin-like growth factor-I gene expression may be mediated by multiple distal signal transducer and activator of transcription 5 binding sites. Endocrinology 149:2230-2240
19. Wang Y, Jiang H 2005 Identification of a distal STAT5-binding DNA region that may mediate growth hormone regulation of insulin-like growth factor-I gene expression. J Biol Chem 280:10955-10963
20. Woelfle J, Chia DJ, Rotwein P 2003 Mechanisms of growth hormone (GH) action. Identification of conserved Stat5 binding sites that mediate GH-induced insulin-like growth factor-I gene activation. J Biol Chem 278:51261-51266
21. Schrem H, Klempnauer J, Borlak J 2004 Liver-enriched transcription factors in liver function and development. Part II: the C/EBPs and D site-binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regeneration, apoptosis, and liver-specific gene regulation. Pharmacol Rev 56:291-330
22. Schrem H, Klempnauer J, Borlak J 2002 Liver-enriched transcription factors in liver function and development. I. The hepatocyte nuclear factor network and liver-specific gene expression. Pharmacol Rev 54:129-158
23. Hayashi Y, Wang W, Ninomiya T, Nagano H, Ohta K, ItohH 1999 Liver enriched transcription factors and differentiation of hepatocellular carcinoma. Mol Pathol 52:19-24
24. Kulik VP, Kavsan VM, van Schaik FM, Nolten LA, Steenbergh PH, Sussenbach JS 1995 The promoter of the salmon insulin-like growth factor I gene is activated by hepatocyte nuclear factor 1. J Biol Chem 270:1068-1073
25. Nolten LA, Steenbergh PH, Sussenbach JS 1995 Hepatocyte nuclear factor 1α activates promoter 1 of the human insulin-like growth factor I gene via two distinct binding sites. Mol Endocrinol 9:1488-1499
26. Nolten LA, van Schaik FM, Steenbergh PH, Sussenbach JS 1994 Expression of the insulin-like growth factor I gene is stimulated by the liver-enriched transcription factors C/EBPα and LAP. Mol Endocrinol 8:1636-1645
27. Umayahara Y, Ji C, Centrella M, Rotwein P, McCarthy TL 1997 CCAAT/enhancer-binding protein δ activates insulin-like growth factor-I gene transcription in osteoblasts. Identification of a novel cyclic AMP signaling pathway in bone. J Biol Chem 272:31793-31800
28. Kaestner KH 2000 The hepatocyte nuclear factor 3 (HNF3 or FOXA) family in metabolism. Trends Endocrinol Metab 11:281-285
29. Clevidence DE, Overdier DG, Tao W, Qian X, Pani L, Lai E, Costa RH 1993 Identification of nine tissue-specific transcription factors of the hepatocyte nuclear factor 3/forkhead DNA-binding-domain family. Proc Natl Acad Sci USA 90:3948-3952
30. Eleswarapu S, JiangH 2005 Growth hormone regulates the expression of hepatocyte nuclear factor-3γ and other liver-enriched transcription factors in bovine liver. J Endocrinol 184:95-105
31. Roux J, Pictet R, Grange T 1995 Hepatocyte nuclear factor 3 determines the amplitude of the glucocorticoid response of the rat tyrosine aminotransferase gene. DNA Cell Biol 14:385-396
32. Wang Y, Price SE, JiangH 2003 Cloning and characterization of the bovine class 1 and class 2 insulin-like growth factor-I mRNAs. Domest Anim Endocrinol 25:315-328
33. Kaestner KH, Hiemisch H, Luckow B, Schütz G 1994 The HNF-3 gene family of transcription factors in mice: gene structure, cDNA sequence, and mRNA distribution. Genomics 20:377-385
34. Navas MA, Vaisse C, Boger S, Heimesaat M, Kollee LA, Stoffel M 2000 The human HNF-3 genes: cloning, partial sequence and mutation screening in patients with impaired glucose homeostasis. Hum Hered 50:370-381
35. Darnell JE Jr 1997 STATs and gene regulation. Science 277:1630-1635
36. John S, Vinkemeier U, Soldaini E, Darnell Jr JE, Leonard WJ 1999 The significance of tetramerization in promoter recruitment by Stat5. Mol Cell Biol 19:1910-1918
37. Nolten LA, Steenbergh PH, Sussenbach JS 1996 The hepatocyte nuclear factor 3β stimulates the transcription of the human insulinlike growth factor I gene in a direct and indirect manner. J Biol Chem 271:31846-31854
38. Lahuna O, Rastegar M, Maiter D, Thissen JP, Lemaigre FP, Rousseau GG 2000 Involvement of STAT5 (signal transducer and activator of transcription 5) and HNF-4 (hepatocyte nuclear factor 4) in the transcriptional control of the hnf6 gene by growth hormone. Mol Endocrinol 14:285-294
39. Lahuna O, Fernandez L, Karlsson H, Maiter D, Lemaigre FP, Rousseau GG, Gustafsson J, Mode A 1997 Expression of hepatocyte nuclear factor 6 in rat liver is sex-dependent and regulated by growth hormone. Proc Natl Acad Sci USA 94:12309-12313
40. Rowland JE, Lichanska AM, Kerr LM, White M, d'Aniello EM, Maher SL, Brown R, Teasdale RD, Noakes PG, Waters MJ 2005 In vivo analysis of growth hormone receptor signaling domains and their associated transcripts. Mol Cell Biol 25:66-77
41. Tan Y, Hughes D, Wang X, Costa RH 2002 Adenovirus-mediated increase in HNF-3β or HNF-3α shows differences in levels of liver glycogen and gene expression. Hepatology 35:30-39
42. Rausa FM, Tan Y, Zhou H, Yoo KW, Stolz DB, Watkins SC, Franks RR, Unterman TG, Costa RH 2000 Elevated levels of hepatocyte nuclear factor 3β in mouse hepatocytes influence expression of genes involved in bile acid and glucose homeostasis. Mol Cell Biol 20:8264-8282
43. Heinemeyer T, Chen X, Karas H, Kel AE, Kel OV, Liebich I, Meinhardt T, Reuter I, Schacherer F, Wingender E 1999 Expanding the TRANSFAC database towards an expert system of regulatory molecular mechanisms. Nucleic Acids Res 27:318-322
44. Lichanska AM, Waters MJ 2008 How growth hormone controls growth, obesity and sexual dimorphism. Trends Genet 24:41-47
45. Ehret GB, Reichenbach P, Schindler U, Horvath CM, Fritz S, Nabholz M,Bucher P 2001DNAbinding specificity of differentSTATproteins. Comparison of in vitro specificity with natural target sites. J Biol Chem 276:6675-6688
46. Verdier F, Rabionet R, Gouilleux F, Beisenherz-Huss C, Varlet P, Muller O, Mayeux P, Lacombe C, Gisselbrecht S, Chretien S 1998 A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B. Mol Cell Biol 18:5852-5860
47. Cirillo LA, Lin FR, Cuesta I, Friedman D, Jarnik M, Zaret KS 2002 Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol Cell 9:279-289
48. Holmqvist PH, Belikov S, Zaret KS, Wrange O 2005 FoxA1 binding to the MMTV LTR modulates chromatin structure and transcription. Exp Cell Res 304:593-603
49. Zhao H, Friedman RD, Fournier RE 2007 The locus control region activates serpin gene expression through recruitment of liver-specific transcription factors and RNA polymerase II. Mol Cell Biol 27:5286-5295
50. Pierrou S, Hellqvist M, Samuelsson L, Enerbäck S, Carlsson P 1994 Cloning and characterization of seven human forkhead proteins: binding site specificity and DNA bending. EMBO J 13:5002-5012
51. Park SH, Waxman DJ 2001 Inhibitory cross-talk between STAT5b and liver nuclear factor HNF3β: impact on the regulation of growth hormone pulse-stimulated, male-specific liver cytochrome P-450 gene expression. J Biol Chem 276:43031-43039
52. Ram PA, Park SH, Choi HK, Waxman DJ 1996 Growth hormone activation of Stat 1, Stat 3, and Stat 5 in rat liver. Differential kinetics of hormone desensitization and growth hormone stimulation of both tyrosine phosphorylation and serine/threonine phosphorylation. J Biol Chem 271:5929-5940
53. Ariyoshi K, Nosaka T, Yamada K, Onishi M, Oka Y, Miyajima A, Kitamura T 2000 Constitutive activation of STAT5 by a point mutation in the SH2 domain. J Biol Chem 275:24407-24413
54. Kobayashi Y, Boyd CK, Bracken CJ, Lamberson WR, Keisler DH, LucyMC 1999 Reduced growth hormone receptor (GHR) messenger ribonucleic acid in liver of periparturient cattle is caused by a specific down-regulation ofGHR1A that is associated with decreased insulinlike growth factor I. Endocrinology 140:3947-3954
55. Xu Q, Walther N, Jiang H 2004 Chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) and hepatocyte nuclear factor 4γ (HNF-4γ) and HNF-4γ regulate the bovine growth hormone receptor 1A promoter through a common DNA element. J Mol Endocrinol 32:947-961
56. Seglen PO 1976 Preparation of isolated rat liver cells. Methods Cell Biol 13:29-83